Christopher D. Ozeroff
2014
In 2014, Christopher D. Ozeroff earned a total compensation of $380.2K as Secretary, Senior Vice President and General Counsel at ARCA biopharma.
Compensation breakdown
| Non-Equity Incentive Plan | $12,350 |
|---|---|
| Option Awards | $15,615 |
| Salary | $273,234 |
| Stock Awards | $66,690 |
| Other | $12,279 |
| Total | $380,168 |
Ozeroff received $273.2K in salary, accounting for 72% of the total pay in 2014.
Ozeroff also received $12.4K in non-equity incentive plan, $15.6K in option awards, $66.7K in stock awards and $12.3K in other compensation.
Rankings
In 2014, Christopher D. Ozeroff's compensation ranked 11,130th out of 13,032 executives tracked by ExecPay. In other words, Ozeroff earned more than 14.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,130 out of 13,032 | 15th |
Division Manufacturing | 4,261 out of 4,966 | 14th |
Major group Chemicals And Allied Products | 1,470 out of 1,686 | 13th |
Industry group Drugs | 1,185 out of 1,365 | 13th |
Industry In Vitro and In Vivo Diagnostic Substances | 59 out of 72 | 18th |
Source: SEC filing on April 27, 2016.
Ozeroff's colleagues
We found one more compensation record of an executive who worked with Christopher D. Ozeroff at ARCA biopharma in 2014.
2014
Michael Bristow
ARCA biopharma
Chief Executive Officer
News
ARCA biopharma CEO Michael Bristow's 2021 pay falls 50% to $527K
November 3, 2022
ARCA biopharma CEO Michael Bristow's 2020 pay jumps 258% to $1.1M
April 21, 2021
ARCA biopharma COO Thomas Keuer's 2019 pay slips 7% to $304K
October 28, 2020
ARCA biopharma COO Thomas Keuer's 2018 pay falls 29% to $327K
October 25, 2019